East Region Formulary
NHS Scotland

Formulary Decisions

Search for the outcome of decisions made by the Formulary Committee

Filter
Select filter(s)
Buprenorphine
Buvidal
Routinely available
SMC (SMC2169)
29/03/2023

Indication

For the treatment of opioid dependence within a framework of medical, social and psychological treatment. Treatment is intended for use in adults and adolescents aged 16 years or over. SMC restriction: Use in patients in whom methadone is not suitable and for whom the use of buprenorphine is conside...

For the treatment of opioid dependence within a framework of medical, social and psychological treatment. Treatment is intended for use in adults and adolescents aged 16 years or over. SMC restriction: Use in patients in whom methadone is not suitable and for whom the use of buprenorphine is considered appropriate.

Therapeutic Area

Central nervous system

Status Description

Routinely available in line with national guidance

Formulation

8mg, 16mg, 24mg, 32mg, 64mg, 96mg, 128 mg prolonged-release solution for injection

Comments

-

Link to Advice

SMC2169

Advice Published

12/08/2019

SMC Submission Type

Full

SMC Status

Restricted